---
title: "20/20 Biolabs (AIDX.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/AIDX.US/norm.md"
symbol: "AIDX.US"
name: "20/20 Biolabs"
parent: "https://longbridge.com/zh-HK/quote/AIDX.US.md"
datetime: "2026-05-21T08:43:30.067Z"
locales:
  - [en](https://longbridge.com/en/quote/AIDX.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AIDX.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AIDX.US/norm.md)
---

# 20/20 Biolabs (AIDX.US) — 財務報表

## 損益表 (USD)

| 指標 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.2541 | -0.1684 | -0.1664 | -0.1664 | -0.2590 |
| ROE | 204498.98% | -1805.87% | -1054.76% | - | - |
| 營業收入 | 538274.00 | 417979.00 | 544440.00 | 544440.00 | 536084.00 |
| 凈利潤 | -1.31M | -825539.00 | -802756.00 | -802756.00 | -1.25M |
| 營業利潤 | -912846.00 | -800173.00 | -808926.00 | -808926.00 | -1.24M |
| 毛利率 | 24.23% | 34.71% | 30.22% | 30.22% | 30.41% |
| 凈利率 | -242.96% | -197.51% | -147.45% | -147.45% | -232.99% |
| 利潤含金量 | - | - | - | - | - |

## 資產負債表 (USD)

| 指標 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 4.14M | 3.24M | 2.70M | 2.70M | 3.58M |
| 權益乘數 | -215.21 | 29.87 | 7.67 | 7.67 | 2.38 |
| 每股凈資產 | -0.0122 | 0.0125 | 0.0631 | 0.0631 | 0.3024 |
| 資產周轉率 | 0.5297 | - | - | - | 0.3522 |
| 現金及短投 | 1.03M | 1.14M | 1.02M | 1.02M | 1.78M |
| 存貨與應收 | 116217.00 | 54762.00 | 61660.00 | 61660.00 | 47164.00 |
| 長期投資 | 661966.00 | 718034.00 | 774625.00 | 774625.00 | 889054.00 |
| 凈債務 | 332652.00 | 14951.00 | -199158.00 | -199158.00 | -944459.00 |

## 現金流量表 (USD)

| 指標 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -511667.00 | -385655.00 | -511199.00 | -511199.00 | -536451.00 |
| 投資現金流 | - | - | - | - | - |
| 融資現金流 | 392799.00 | 506561.00 | 131169.00 | 131169.00 | 110026.00 |
| 自由現金流 | -53608.00 | -37197.00 | -353652.00 | - | - |
| 現金流充裕率 | - | - | - | - | - |
| 舉債與償債 | 411911.00 | 506561.00 | 35000.00 | 35000.00 | - |
| 資本支出 | - | - | - | - | - |